Children with cancer are being treated with drugs that are as old as 40 years old. Dr. Eugenie Kleinerman says this is because the FDA is not approving new drugs because of safety concerns she thinks are unreasonable.
On Friday morning, Dr. Kleinerman asked a congressional panel to find ways to speed up approval of new cancer drugs for children.
Also, local congressman Michael McCaul introduced a bill he calls the Creating Hope Act. Among other things, it would speed up the FDA review process for profitable drugs, in return for those companies developing treatments for rare pediatric diseases.